Repatriating the Value of Clinical Intellect

Protect your practice against the "Sustainability Test" of 2026. The RegenMed Dividend Model transforms high-fidelity clinical evidence into a high-margin revenue engine, returning 85% of net data license fees directly to the clinical source.

Observational Protocols

Go Deeper

The Gap Between Production and Revenue

The Problem: While production cycles remain intensive, revenue is being eroded by "quiet" cuts to Relative Value Units (RVUs) and persistently high operating costs.

The Consequences:

The Lost Asset

Currently, the data your practice generates is treated as "Data Exhaust"— a secondary byproduct captured for billing and administration.

The Exploitation Gap

External aggregators often scrape this messy, "inferred" data to sell it for research, leaving the physician with the administrative burden and 0% of the financial upside.

Value is Created at the Point of Capture

The Logic: Secondary data (Scraping the Exhaust) is inherently low-value because it requires massive cleaning and often leads to "guesses" about clinical outcomes. By Structuring at the Source, you create Deterministic Evidence that commands a "Veracity Premium" from Life Sciences and AI developers.

The Engineering Pillars:

Zero-Lift Capture

Our digital templates integrate with your workflow, allowing you to "mint" structured assets as a byproduct of care.

Deterministic Integrity

Because the evidence is verifiable back to the primary clinical observation, it is regulatory-ready and immune to the "inference gap" that plagues legacy datasets.

Direct Repatriation

We bypass the aggregators. 85% of the net value from licensed Evidence Assets is returned to the participating physicians in your Circle.

Sustainability & Sovereignty

Offsetting RVU Cuts

The Dividend Model provides a high-margin revenue stream that functions independently of traditional production cycles, shielding the practice from federal and private payer cuts.

Funding Research Sovereignty

Use your dividends to fund internal research into nonoperative care or innovative protocols that prove your clinical value to payers.

Reducing Administrative Attrition

By capturing high-fidelity evidence at the source, you create a Structured Note Defense that reduces prior authorization friction and administrative "hoops".